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This leaves us with the hypothesis that A82V may well have promoted spread of Ebola during the West African epidemic, but that A82V likely did not arise due to selection to promote spread. A similar observation exists in the influenza literature, where transient spill-over events from the animal reservoir often show a characteristic pattern in which signature adaptations occur very early on in the human-to-human transmission chain (Chen et al., 2006) . However, in previous influenza pandemics, the acquisition of genetic data lagged behind epidemic spread, and so the initial key events in the transmission chain were not obvious.
For the West African Ebola epidemic, case detection and sequencing was rapid enough to observe adaptation in real time. This creates the opportunity for tools to track and identify the spread of adaptive variants to improve public health response. In that respect, the two studies appearing in this issue of Cell set the stage and the standard to take field observations and forensically tie them to molecular adaptations via detailed laboratory reconstructions Generation of biologic diversity is a cornerstone of immunity, yet the tools to investigate the causal influence of genetic and environmental factors have been greatly limited. Studies from the Human Functional Genomics Project, presented in Cell and other Cell Press journals, integrate environmental and genetic factors with the direction and magnitude of immune responses to decipher inflammatory disease pathogenesis.
The first step in defining the inflammatory nature of human infectious and autoimmune diseases came from breakthroughs in light microscopy, beginning over two centuries ago, through the examination of organs in diseased patients. Following waves of subsequent technological advance, many distinct clinical syndromes have since been identified, and it has become clear that both genetic inheritability and environmental factors play important roles. Yet, until recently, the tools to investigate causality by these factors were greatly limited, and why human immune responses are so variable between individuals has largely remained unknown. A critical turning point toward addressing these questions has been the sequencing of the human genome and the subsequent adaptation of technologies to facilitate whole-genome investigation of germlines, transcriptomes, and epigenomes. Genome-wide association scans (GWAS) have, for example, allowed the unbiased clustering of genetic variation defining human autoimmune diseases (Fahr et al., 2015) , and we now know that a risk allele in one disease may be protective in another, thus elucidating the biologic ''vector,'' that is, the direction and magnitude of an effect is essential in deciphering the emerging genomics data. Through the large-scale examination of immune responses and other physiological information in a variety of cohorts, the Human Functional Genomics Project takes an important step in this direction. With these and other studies, we are beginning to tease apart the basis for human variability in immune responses.
The immune system is the perfect target tissue for studying human variability and the intersection of genes and the environment. Generation of biologic diversity is a cornerstone of protective immunity. As genetic recombination is essential for intra-individual diversification of lymphocyte receptors to allow protection from a multitude of pathogens, inter-individual immune heterogeneity prevents widespread susceptibility to any one challenge. The spectrum of immunity encompasses both variable responses mounted by healthy individuals and immunopathologies, including autoimmune disorders. Thus, defining immune heterogeneity and its contributing factors could have widespread implications for how we think about protective immunity in healthy individuals as well as offer a better understanding of risk factors for immune-mediated diseases and improved prevention and treatment options.
In this issue, Ter Horst et al. (2016) examine inflammatory markers and cytokines after stimulation with 19 bacterial, fungal, viral, and non-microbial metabolic stimuli. They report a striking annual seasonal dependency, which may in part explain seasonal dependency in human inflammatory diseases. Li et al. (2016) , also in this issue, present findings that reveal how genetic variants impact cytokine production in response to stimuli representative of specific pathogen challenges. They demonstrate that different cytokines have different levels of genetic influence, which is a critical concept for host defense and disease as cytokines are central to orchestrating overall responses and can drive pathology when dysregulated. This is complemented by the work of Ter Horst et al. (2016), who explore how the integration of environmental and intrinsic host factors shape the nature of the immune response. Specifically, they measure cytokine production after challenge with several environmental factors previously linked to autoimmunity including vitamin D, seasonality, and age. They show that age and gender have important effects on cytokine production, including increased IL-6 and IL-1Ra in older individuals, which could support the notion of inflammation accompanying aging, or ''inflammaging.'' Delving deeper into a specific immune setting, Oosting et al. (2016) investigate both monocyte-and T cell-derived cytokines and find that non-genetic and genetic host factors exert important effects on Borrelia-induced cytokine responses. Age strongly impairs IL-22 responses, while several independent quantitative trait loci (QTL) have a strong impact on Borrelia-induced cytokine production. Aguirre-Gamboa et al. (2016) likewise examine genetic and environmental factors on circulating immune cell populations and immunoglobulin concentrations. Interestingly, heritability estimates show that variations in T cell frequencies are more strongly driven by genetic factors, while B cells are more environmentally influenced. Additionally, QTL mapping identifies eight independent genomic loci associated with leukocyte count variation, and these QTLs are enriched among GWAS-single nucleotide polymorphisms (SNPs) reported to increase susceptibility to immune-mediated diseases. Rounding out this package, Schirmer et al. (2016) investigate the role of the microbiome in determining immune responses, studying variation among subjects in cytokine secretion in response to microbial stimulations and gut microbial communities. They observe microbiome-cytokine interaction patterns that are stimulus-specific, cytokine-specific, and cytokine-and stimulus-specific. For instance, TNFa and IFN production are associated with palmitoleic acid metabolism and tryptophan degradation to tryptophol by the microbiome. Taken together, these studies provide a comprehensive resource on how immune response vectors are determined by environmental, genetic, and microbial factors.
That immunity is influenced by hereditability and the environment is well-known, but how these factors synergize to influence immune function is not. Together, these works weave a tapestry of environmental and genetic factors and provide insight into how they mediate autoimmunity and inflammatory responses to microbes (Figure 1) . Autoimmune diseases present an especially relevant context to study the intersection of these factors, as extensive genomic and epidemiological studies suggest that autoimmunity results from the coincident interaction of an environmental trigger with a genetically predisposed individual. In other words, it's neither bad genes nor a bad environment but an unfortunate nexus of the two. Thus, creating a matrix of how genetic and environmental factors interact in defining an immune response is a critical next step in understanding disease pathogenesis.
GWAS investigating common human inflammatory diseases has revealed hundreds of variants associated with risk of developing autoimmune diseases. Each of those haplotypes has a small effect on disease risk, and they are strongly shared among the different autoimmune diseases (Fahr et al., 2015) . However, the effect of risk haplotypes on disease risk is small, even though these genetic variants exert major biologic effects. One recent example is the 20-fold increase in the NFkB response driven by a risk variant for multiple sclerosis that maps near the NFkB1 region . In this phenotype-genotype investigation of normal subjects, a single genotype is examined for function. In comparison, the current study by Li et al. (2016) provides a more comprehensive roadmap for examining how genetic variants dictate cytokine responses, performing large-scale ''reverse genetics'' based on phenotype. This represents the first comprehensive cataloging of immune vectors that is central to the observation that a risk variant in one autoimmune disease is protective in another. Moreover, a therapy that may have dramatic clinical efficacy in one disease, such as anti-TNF monoclonal antibodies (e.g., for rheumatoid arthritis [Krintel et al., 2012] or inflammatory bowel disease; Heel et al., 2002) can make multiple sclerosis worse (Sicotte and Voskuhl, 2001) . That all of these ailments have a significant number of genetic variants in the TNF pathway highlights the need to determine the disease haplotype's immune vector in their contributions to disease.
Finally, there is a growing appreciation for the impact of the microbiome on immune system development for mounting effector responses and maintaining tolerance. Consequently, a dysregulated microbiome can have profound effects on human health. The effects on immunity elicited by commensals and the heterogeneity of the microbiome between individuals has provided obstacles for pinpointing the microbial characteristics that contribute to disease. Thus, the recent investigation by Vatanen et al. (2016) uniquely identifies the contribution of the microbiome to human disease. In it, they examine the heightened incidence of the autoimmune disease type 1 diabetes in Finland and Estonia and the lower incidence in Russia to elucidate overarching differences in the microbiome that could contribute to this discrepancy. They identify the predominance of Bacteriodes in Finnish and Estonian populations, which contributes to impaired immune education by the reduced immunogenicity of its lipopolysaccharide. Schirmer et al. (2016) demonstrate that the microbiome alters how the host responds to the microbes it encounters and that these systemic impacts might be mediated by circulating microbial products. Their delineation of the immune effects mediated by commensal microbes provides a basis for meaningful comparison between individuals, even with highly variable species composition, that will help tackle how the microbiome can be manipulated to maintain health.
The identification of genetic variants influencing cytokine responses provides a platform for driving future functional experiments to elucidate underlying pathways. For example, altering single nucleotides by CRISPR/Cas9 of haplotypes identified in these investigations followed by paired single-cell RNA sequencing could provide a detailed view of the transcription factors and regulatory elements that mediate immune functions affected by genetic factors. Moreover, the immune vectors associated with genetic variation can be overlaid on the genome-wide association scans to better determine the biology driven by genetic variation. These data from the Human Functional Genomics Project analyzed together with autoimmune association studies and response to treatment may provide insight into the question posed previously as to why one therapy may have significant clinical efficacy in one autoimmune disease, but make another worse.
In summary, combining large-scale analysis of immune variability with accompanying functional information allows examination of immunity at an unprecedented level. The Human Functional Genomics Project is generating invaluable information that will drive future studies of immune-mediated diseases and an understanding as to how variation between individuals underlies disease mechanisms. Finally, future studies of disease cohorts in which immune vectors are elucidated in relation to genetic and environmental background to identify the interplay of factors altering immune responses will aid the development of ''precision medicine'' for autoimmune and other immune-mediated diseases.
